Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.62 |
| ▸ | HTR2A | P28223 | 2/20 | 0.62 |
| ▸ | DPP4 | P27487 | 2/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | SCN4A | P35499 | 2/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1952916 | 1.00 | TAAR1 (0.62) | TAAR1HTR2ADPP4F2SCN4A | |
| SCHEMBL507195 | 1.00 | TAAR1 (0.62) | TAAR1HTR2ADPP4F2SCN4A | |
| Hydrochloric Acid SCHEMBL18547879 | 0.97 | TAAR1 (0.59) | TAAR1HTR2ADPP4F2SCN4A | |
| Hydrochloric Acid SCHEMBL28583636 | 0.97 | TAAR1 (0.59) | TAAR1HTR2ADPP4F2SCN4A | |
| Hydrochloric Acid SCHEMBL6694632 | 0.97 | TAAR1 (0.59) | TAAR1HTR2ADPP4F2SCN4A | |
| Hydrochloric Acid SCHEMBL4696174 | 0.97 | TAAR1 (0.59) | TAAR1HTR2ADPP4F2SCN4A | |
| SCHEMBL15558709 | 0.89 | TAAR1 (0.50) | TAAR1HTR2ADPP4F2SCN4A | |
| SCHEMBL6742097 | 0.89 | TAAR1 (0.50) | TAAR1HTR2ADPP4F2SCN4A | |
| Toluene SCHEMBL28855142 | 0.89 | TAAR1 (0.50) | TAAR1HTR2ASCN4A | |
| Acetic Acid SCHEMBL2393284 | 0.87 | GABBR2 (0.50) | TAAR1HTR2ASCN4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 903 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3256420-B1 | USE OF MODIFIED AMINES SCALE INHIBITORS IN WET PROCESS PHOSPHORIC ACID PRODUCTION | CYTEC IND INC (US) | 2025-04-23 | — | — | EP | claimed |
| CN-118807618-A | Fixed bed reactor of ruthenium-based catalyst for preparing chlorine by hydrogen chloride oxidation and preparation process | 南通沃兰化工有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-117659018-A | Chiral C1 symmetrical imidazole-pyridine-imidazolidinone tridentate nitrogen ligand, synthesis and application thereof | 河南师范大学 | 2024-03-08 | — | — | CN | claimed |
| CN-114621098-B | Method for preparing diamine compound by olefin ammonification | 中国科学院大连化学物理研究所 | 2023-06-13 | — | — | CN | claimed |
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2022-06-23 | — | — | US | claimed |
| CN-114621098-A | Method for preparing diamine compound by ammoniating olefin | 中国科学院大连化学物理研究所 | 2022-06-14 | — | — | CN | claimed |
| US-10906828-B2 | Modified amines useful as scale inhibitors in wet process phosphoric acid production | CYTEC INDUSTRIES INC. (US) | 2021-02-02 | — | — | US | claimed |
| WO-2020130592-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | 서울대학교산학협력단 | 2020-06-25 | — | — | WO | claimed |
| US-10604691-B2 | Reversible aminal gel compositions, methods, and use | SAUDI ARABIAN OIL COMPANY (SA) | 2020-03-31 | — | — | US | claimed |
| US-20200031791-A1 | SHIKIMATE ANALOGUES AND METHODS OF USE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2020-01-30 | — | — | US | claimed |
| US-20040063779-A1 | 1-Phenyl-1,2-diaminoethane derivatives as modulators of the chemokine receptor activity | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-04-01 | — | — | US | claimed |
| US-20030191340-A1 | Catalytic compositions and methods for asymmetric allylic alkylation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-10-09 | — | — | US | claimed |
| EP-1295860-A2 | Process for the preparation of sorbic acid by thermal decomposition | Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) | 2003-03-26 | — | — | EP | claimed |
| EP-0559835-A4 | — | — | 1994-03-02 | — | — | EP | claimed |
| US-4935409-A | Animal growth regulators | BAYER AKTIENGESELLSCHAFT (DE) | 1990-06-19 | — | — | US | claimed |
| EP-0144980-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 3-AMINOCARBOXYLIC ACIDS (ESTERS) | LONZA AG (CH) | 1989-07-12 | — | — | EP | claimed |
| US-4806667-A | Promoting production of useful livestock with silylated aminophenylethylamine derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 1989-02-21 | — | — | US | claimed |
| US-4670423-A | Monosilylated aminophenylethylamine derivatives, a process for their preparation, and their use for promoting growth | BAYER AKTIENGESELLSCHAFT (DE) | 1987-06-02 | — | — | US | claimed |
| US-4477387-A | ANTILTUMOR AGENTS | OTSUKA CHEMICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | claimed |
| EP-0055300-A1 | PLATINUM (II) COMPLEXES AND ANTINEOPLASTIC AGENTS CONTAINING SAME AS EFFECTIVE INGREDIENTS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 1982-07-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | HCN4, SLC46A1, FES | TAAR1 4232/4885HTR2A 853/4885DPP4 3442/4885 |
| US-20030191340-A1 | Catalytic compositions and methods for asymmetric allylic alkylation | MPG, UNG, APOBEC3C | TAAR1 2064/4885HTR2A 4148/4885DPP4 2820/4885 |
| US-20200031791-A1 | SHIKIMATE ANALOGUES AND METHODS OF USE | GRIK3, SYMPK, SIK3 | TAAR1 3056/4885HTR2A 814/4885DPP4 4323/4885 |
| US-20040063779-A1 | 1-Phenyl-1,2-diaminoethane derivatives as modulators of the chemokine receptor activity | CCR1, CCR3, CCR2 | TAAR1 85/4885HTR2A 1255/4885DPP4 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.